|
BEAZ ★ India, 2008-12-02 08:49 (6420 d 01:20 ago) Posting: # 2854 Views: 3,283 |
|
|
Dear All, I welcome your comments and suggestion for the below query The FDA guidance "Handling and Retension of BA and BE Testing Samples" state that reserve sample should be 5 times to perform the release tests. Is the release test include only dissolution or the entire tests which are performed as per the specifications? What about injectable suspension and oral suspensions. Thanks and regards — Alhas |
|
krishnamurthy ca ☆ 2008-12-02 11:18 (6419 d 22:51 ago) @ BEAZ Posting: # 2861 Views: 2,822 |
|
|
BEAZ ★ India, 2008-12-03 08:54 (6419 d 01:14 ago) @ krishnamurthy ca Posting: # 2872 Views: 2,748 |
|
|
Dear Krishnamurthy Thank you and in case of injectable we will be performing test for sterlity, is this come under release test? beacause if we consider this then there will be a remarkable increase in the quantity of retention. rgs — Alhas |
|
krishnamurthy ca ☆ 2008-12-04 05:54 (6418 d 04:14 ago) @ BEAZ Posting: # 2874 Views: 2,721 |
|
|
Dear Alhas tests for sterility is for the quality of the product (agree that its a release test), and this is in no way performed to identify or determine the potency of the active ingredient. hence such tests can be skipped. others can comment. rgs Krishnamurthy -- Edit: Full quote removed (like in this post of the same thread). Please see this post! On the next occasion your account will be blocked without further notice. [Helmut] |
your comments and suggestion for the below query
injectable suspension and oral suspensions. 